BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4006481)

  • 1. Granulocyte adherence changes during hemodialysis.
    Aljama P; Martin-Malo A; Pérez R; Castillo D; Torres A; Velasco F
    Contrib Nephrol; 1985; 46():75-82. PubMed ID: 4006481
    [No Abstract]   [Full Text] [Related]  

  • 2. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis.
    Thylén P; Lundahl J; Fernvik E; Hed J; Svenson SB; Jacobson SH
    Am J Nephrol; 1992; 12(6):393-400. PubMed ID: 1292337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD31 expression on leukocytes is downregulated in vivo during hemodialysis.
    Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki N; Tomimatsu I; Ushida Y; Hosono F; Maeda K
    Nephron; 2001 Oct; 89(2):153-60. PubMed ID: 11549897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of calcium channel blockers on granulocyte activation during hemodialysis.
    Haag-Weber M; Poppek C; Ranucht H; Schollmeyer P; Hörl WH
    Contrib Nephrol; 1989; 74():106-12. PubMed ID: 2702126
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: absence of an acute benefit on expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Glorieux G; Waterloos MA; De Smet R; Lesaffer G; Lameire N
    Am J Kidney Dis; 2000 Dec; 36(6):1140-6. PubMed ID: 11096038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood flow dependent granulocyte activation in membranes with and without complement activation.
    Böhler J; Donauer J; Schollmeyer P; Hörl WH
    Adv Exp Med Biol; 1991; 297():215-24. PubMed ID: 1767753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte activation during hemodialysis.
    Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
    Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes.
    Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
    Contrib Nephrol; 1989; 74():58-65. PubMed ID: 2702147
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient reactions and granulocyte degranulation during hemodialysis with cuprophane and polycarbonate membranes. A double-blind study.
    Danielson BG; Hällgren R; Venge P
    Blood Purif; 1986; 4(1-3):147-50. PubMed ID: 3524607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodialysis leucopenia as an index of membrane biocompatibility.
    Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
    Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes.
    Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH
    Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of leukotriene B4 formation by dialyzer membranes.
    Schiffl H; Strasser T
    Biomater Artif Cells Artif Organs; 1990; 18(5):585-90. PubMed ID: 1965950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cuprophan, hemophan and polysulfone membranes on the oxidative metabolism, degranulation reaction, enzyme release and pulmonary sequestration of granulocytes.
    Kolb G; Fischer W; Schoenemann H; Bathke K; Höffken H; Müller T; Lange H; Joseph K; Havemann K
    Contrib Nephrol; 1989; 74():10-21. PubMed ID: 2562018
    [No Abstract]   [Full Text] [Related]  

  • 14. [Erythropoietin].
    Mori H; Hiraoka K; Fujita Y
    Nihon Rinsho; 1991 Dec; 49 Suppl():170-4. PubMed ID: 1808250
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of membrane contact in hemodialysis-induced granulocyte activation.
    Kolb G; Nolting C; Eckle I; Müller T; Lange H; Havemann K
    Nephron; 1991; 57(1):64-8. PubMed ID: 2046816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The next generation of dialysis membranes--barriers or pathways?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
    Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
    Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
    [No Abstract]   [Full Text] [Related]  

  • 19. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis.
    Tielemans CL; Delville JP; Husson CP; Madhoun P; Lambrechts AM; Goldman M; Vanherweghem JL
    Clin Nephrol; 1993 Mar; 39(3):158-65. PubMed ID: 8096446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone.
    Amato M; Salvadori M; Bergesio F; Messeri A; Filimberti E; Morfini M
    Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.